HER2-IN-15
HER2-IN-15 (Compound 1) is an inhibitor for HER2, which inhibits the Her YVMA exon 20 insertion mutation (HER2 YVMA) with an IC50 IC50 [1].
Product Specifications
UNSPSC
12352005
Target
EGFR
Type
Reference compound
Related Pathways
JAK/STAT Signaling; Protein Tyrosine Kinase/RTK
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/her2-in-15.html
Solubility
DMSO : 50 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
CC1=CC(NC2=NC=NN3C=CC(C4CN(C4)C(/C=C/CN(C)C)=O)=C23)=CC=C1OC5=CC6=NC=NN6C=C5
Molecular Formula
C28H29N9O2
Molecular Weight
523.59
References & Citations
[1]Svitlana KULYK, et al., Compounds and methods for modulating her2. Patent WO2024044570.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
ErbB2/HER2
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6459648-01 0.2 mL
TAF1B (TATA box-Binding Protein-Associated Factor RNA Polymerase I Subunit B, RNA Polymerase I-specific TBP-Associated Factor 63kD, TAFI63, TATA box-Binding Protein-Associated Factor 1B, TBP-Associated Factor 1B, Transcription initiation Factor SL1/TIF-IB
Ask
View Details 
MBS6459648-02 5x 0.2 mL
TAF1B (TATA box-Binding Protein-Associated Factor RNA Polymerase I Subunit B, RNA Polymerase I-specific TBP-Associated Factor 63kD, TAFI63, TATA box-Binding Protein-Associated Factor 1B, TBP-Associated Factor 1B, Transcription initiation Factor SL1/TIF-IB
Ask
View Details